Selection of DNA aptamer recognizing CD44 for high-efficiency capture of circulating tumor cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selection of DNA aptamer recognizing CD44 for high-efficiency capture of circulating tumor cells
Authors
Keywords
-
Journal
TALANTA
Volume 262, Issue -, Pages 124728
Publisher
Elsevier BV
Online
2023-05-24
DOI
10.1016/j.talanta.2023.124728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Directed Evolution of Aptamer Discovery Technologies
- (2022) Diana Wu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Multimodal CTC detection using stem cell antigen-specific immunosilica particles and immunofluorescent quantum dots
- (2022) Jeladhara Sobhanan et al. NPG Asia Materials
- Circulating tumor cells in precision medicine: challenges and opportunities
- (2022) Brittany Rupp et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Greatly Enhanced CTC Culture Enabled by Capturing CTC Heterogeneity Using a PEGylated PDMS–Titanium–Gold Electromicrofluidic Device with Glutathione-Controlled Gentle Cell Release
- (2022) Elyahb A. Kwizera et al. ACS Nano
- Circulating tumor cell isolation for cancer diagnosis and prognosis
- (2022) Zicheng Deng et al. EBioMedicine
- Tannic Acid (TA)-Functionalized Magnetic Nanoparticles for EpCAM-Independent Circulating Tumor Cell (CTC) Isolation from Patients with Different Cancers
- (2021) Pi Ding et al. ACS Applied Materials & Interfaces
- Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
- (2021) Luc Cabel et al. BRITISH JOURNAL OF CANCER
- Aptamer-Based Detection of Circulating Targets for Precision Medicine
- (2021) Lingling Wu et al. CHEMICAL REVIEWS
- Ultradense Erythrocyte Bionic Layer Used to Capture Circulating Tumor Cells and Plasma-Assisted High-Purity Release
- (2021) Taoye Zhang et al. ACS Applied Materials & Interfaces
- CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
- (2021) Desiree Loreth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer
- (2021) Dhruvajyoti Roy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
- (2021) Guillaume Belthier et al. Cancers
- Anti-CD44 DNA Aptamers Selectively Target Cancer Cells
- (2020) Aleksandra Pęcak et al. Nucleic Acid Therapeutics
- Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells
- (2020) Ningqin Lin et al. ACS Applied Materials & Interfaces
- Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
- (2020) Zhonghai Sun et al. Oncology Letters
- Dopamine-functionalized hyaluronic acid microspheres for effective capture of CD44-overexpressing circulating tumor cells
- (2020) Xiuping Li et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- CD44 as a tumor biomarker and therapeutic target
- (2020) Hanxiao Xu et al. Experimental Hematology & Oncology
- High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles
- (2019) Zhili Wang et al. ACS Applied Materials & Interfaces
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
- (2018) Xia Liu et al. Cancer Discovery
- Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
- (2017) Sherif Abdelaziz Ibrahim et al. Molecular Cancer
- Appropriate Size of Magnetic Nanoparticles for Various Bioapplications in Cancer Diagnostics and Therapy
- (2016) Xiaomeng Guo et al. ACS Applied Materials & Interfaces
- Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
- (2016) B. L. Khoo et al. Science Advances
- Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?
- (2015) Nick Beije et al. CANCER TREATMENT REVIEWS
- Challenges in circulating tumor cell detection by the CellSearch system
- (2015) Kiki C. Andree et al. Molecular Oncology
- Hyaluronic Acid-Functionalized Electrospun Polyvinyl Alcohol/Polyethyleneimine Nanofibers for Cancer Cell Capture Applications
- (2015) Yili Zhao et al. Advanced Materials Interfaces
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Identification of DNA Aptamers toward Epithelial Cell Adhesion Molecule via Cell-SELEX
- (2014) Ji Won Kim et al. MOLECULES AND CELLS
- DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration
- (2014) Joji Iida et al. PLoS One
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
- (2013) Ramdane Harouaka et al. PHARMACOLOGY & THERAPEUTICS
- In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
- (2013) Nidaa Ababneh et al. Nucleic Acid Therapeutics
- Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
- (2010) Anoma Somasunderam et al. BIOCHEMISTRY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started